[Significance of combined arginine-betaine-sorbitol therapy in the treatment of metabolic liver diseases].
D000328:Adult; D000368:Aged; D001120:Arginine / Q000627:therapeutic use*; D001622:Betaine / Q000627:therapeutic use; D006801:Humans; D008107:Liver Diseases / Q000188:drug therapy*; D008875:Middle Aged; D000644:Quaternary Ammonium Compounds / Q000627:therapeutic use*; D013012:Sorbitol / Q000627:therapeutic use*
D000644:Quaternary Ammonium Compounds; D001622:Betaine; D013012:Sorbitol; D001120:Arginine
Interêt de l'association arginine-bétaine-sorbitol dans le traitement des troubles métaboliques du foie.